Trends in Cancer-Center Spending on Advertising in the United States, 2005 to 2014 | Oncology | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Abel  GA, Burstein  HJ, Hevelone  ND, Weeks  JC.  Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.  J Clin Oncol. 2009;27(25):4182-4187.PubMedGoogle ScholarCrossref
2.
Abel  GA.  Public advertising by cancer centers: are more data needed?  Ann Intern Med. 2014;160(12):870-871.PubMedGoogle ScholarCrossref
3.
Schenker  Y, Arnold  RM, London  AJ.  The ethics of advertising for health care services.  Am J Bioeth. 2014;14(3):34-43.PubMedGoogle ScholarCrossref
4.
Vater  LB, Donohue  JM, Arnold  R, White  DB, Chu  E, Schenker  Y.  What are cancer centers advertising to the public?: a content analysis.  Ann Intern Med. 2014;160(12):813-820.PubMedGoogle ScholarCrossref
5.
Rosenthal  E. Ask your doctor if this ad is right for you. New York Times. February 27, 2016:SR1. http://www.nytimes.com/2016/02/28/sunday-review/ask-your-doctor-if-this-ad-is-right-for-you.html. Accessed March 8, 2016.
6.
Tomycz  ND.  A profession selling out: lamenting the paradigm shift in physician advertising.  J Med Ethics. 2006;32(1):26-28.PubMedGoogle ScholarCrossref
Research Letter
August 2016

Trends in Cancer-Center Spending on Advertising in the United States, 2005 to 2014

Author Affiliations
  • 1Indiana University School of Medicine, Indianapolis, Indiana
  • 2Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania
  • 3Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
  • 4Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, Pennsylvania
JAMA Intern Med. 2016;176(8):1214-1216. doi:10.1001/jamainternmed.2016.0780

In the United States, cancer centers commonly advertise clinical services directly to the public. Potential benefits of such advertising include informing patients about available treatments and reducing the stigma of cancer.1,2 Potential risks include misleading vulnerable patients and creating false hopes, increasing demand for unnecessary tests and treatments, adversely affecting existing physician-patient relationships, and increasing health care costs.3,4 Understanding the trends in the advertising spending of cancer centers and the characteristics of the centers that spend the most can inform the debate about the effect of their advertisements. We hypothesized that advertising spending by cancer centers has increased and is concentrated among for-profit cancer centers.

×